- Home
- RNAZ vs GURE Comparison
RNAZ vs GURE Comparison
Compare RNAZ & GURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- GURE
- Stock Information
- Founded
- RNAZ 2016
- GURE 2006
- Country
- RNAZ United States
- GURE China
- Employees
- RNAZ N/A
- GURE N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- GURE Major Chemicals
- Sector
- RNAZ Health Care
- GURE Industrials
- Exchange
- RNAZ Nasdaq
- GURE Nasdaq
- Market Cap
- RNAZ 8.7M
- GURE 9.5M
- IPO Year
- RNAZ 2021
- GURE 1992
- Fundamental
- Price
- RNAZ $15.00
- GURE $0.55
- Analyst Decision
- RNAZ Strong Buy
- GURE
- Analyst Count
- RNAZ 1
- GURE 0
- Target Price
- RNAZ $280.00
- GURE N/A
- AVG Volume (30 Days)
- RNAZ 13.8K
- GURE 129.2K
- Earning Date
- RNAZ 11-13-2025
- GURE 11-18-2025
- Dividend Yield
- RNAZ N/A
- GURE N/A
- EPS Growth
- RNAZ N/A
- GURE N/A
- EPS
- RNAZ N/A
- GURE N/A
- Revenue
- RNAZ N/A
- GURE $13,919,011.00
- Revenue This Year
- RNAZ N/A
- GURE N/A
- Revenue Next Year
- RNAZ N/A
- GURE N/A
- P/E Ratio
- RNAZ N/A
- GURE N/A
- Revenue Growth
- RNAZ N/A
- GURE N/A
- 52 Week Low
- RNAZ $6.15
- GURE $0.50
- 52 Week High
- RNAZ $739.20
- GURE $1.47
- Technical
- Relative Strength Index (RSI)
- RNAZ 84.37
- GURE 38.11
- Support Level
- RNAZ $10.32
- GURE $0.50
- Resistance Level
- RNAZ $12.28
- GURE $0.70
- Average True Range (ATR)
- RNAZ 0.87
- GURE 0.07
- MACD
- RNAZ 0.57
- GURE -0.01
- Stochastic Oscillator
- RNAZ 91.34
- GURE 30.15
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
About GURE Gulf Resources Inc. (NV)
Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.